Application 1101
Repetitive Transcranial Magnetic Stimulation (rTMS)
Repetitive Transcranial Magnetic Stimulation (rTMS)
Application Name | Repetitive Transcranial Magnetic Stimulation (rTMS) |
| Advisory Panels | Dr Kwun Fong (Chair and MSAC member) Dr Mary Turner (MSAC member) Professor Philip Thompson (Australian Association of Neurologists nominee) Professor Philip Mitchell (Royal Australian and New Zealand College of Psychiatrists nominee) Dr Steven Kan (Royal Australian College of General Practitioners nominee) Ms Margaret Springgay (Consumers' Health Forum of Australia nominee) |
| Date Received by MSAC Secretariat | August 2005 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | This assessment was considered by the MSAC at the 9 March 2007 meeting. MSAC has considered the safety, effectiveness and cost-effectiveness of repetitive transcranial magnetic stimulation (rTMS) for moderate to severe refractory treatment resistant depression compared with electro convulsive therapy (ECT). MSAC finds evidence that rTMS is safe, less invasive than ECT. MSAC finds limited evidence that rTMS may be less effective than ECT. The financial and resource implications will depend upon the mix of patients who have rTMS, including uptake amongst patients who would otherwise not have ECT. MSAC does not support public funding at this time due to insufficient evidence. |
| Stage 4 - Decision | Endorsed by the Minister for Health and Ageing on 4 June 2007 |
| Stage 5 - Implementation |  |
Page currency, Latest update: 01 June, 2009
